Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP637776.RA9S3esV0tziJAHDG61QhFeJBTv3PNB5imPN11bvpi_Nk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP637776.RA9S3esV0tziJAHDG61QhFeJBTv3PNB5imPN11bvpi_Nk130_assertion type Assertion NP637776.RA9S3esV0tziJAHDG61QhFeJBTv3PNB5imPN11bvpi_Nk130_head.
- NP637776.RA9S3esV0tziJAHDG61QhFeJBTv3PNB5imPN11bvpi_Nk130_assertion description "[Here, we tested the hypothesis that chemokine gene therapy with fractalkine (FKN) induces an effective anti-neuroblastoma immune response amplified by targeted IL-2 using the anti-GD2 antibody ch14.18 fused with IL-2 (ch14.18-IL-2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637776.RA9S3esV0tziJAHDG61QhFeJBTv3PNB5imPN11bvpi_Nk130_provenance.
- NP637776.RA9S3esV0tziJAHDG61QhFeJBTv3PNB5imPN11bvpi_Nk130_assertion evidence source_evidence_literature NP637776.RA9S3esV0tziJAHDG61QhFeJBTv3PNB5imPN11bvpi_Nk130_provenance.
- NP637776.RA9S3esV0tziJAHDG61QhFeJBTv3PNB5imPN11bvpi_Nk130_assertion SIO_000772 15953676 NP637776.RA9S3esV0tziJAHDG61QhFeJBTv3PNB5imPN11bvpi_Nk130_provenance.
- NP637776.RA9S3esV0tziJAHDG61QhFeJBTv3PNB5imPN11bvpi_Nk130_assertion wasDerivedFrom befree-20140225 NP637776.RA9S3esV0tziJAHDG61QhFeJBTv3PNB5imPN11bvpi_Nk130_provenance.
- NP637776.RA9S3esV0tziJAHDG61QhFeJBTv3PNB5imPN11bvpi_Nk130_assertion wasGeneratedBy ECO_0000203 NP637776.RA9S3esV0tziJAHDG61QhFeJBTv3PNB5imPN11bvpi_Nk130_provenance.